Synthesis and in silico studies of triazene-substituted sulfamerazine derivatives as acetylcholinesterase and carbonic anhydrases inhibitors.


Journal

Archiv der Pharmazie
ISSN: 1521-4184
Titre abrégé: Arch Pharm (Weinheim)
Pays: Germany
ID NLM: 0330167

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 14 07 2020
revised: 27 08 2020
accepted: 01 09 2020
pubmed: 29 9 2020
medline: 26 8 2021
entrez: 28 9 2020
Statut: ppublish

Résumé

A novel series of sulfonamides, 4-(3-phenyltriaz-1-en-1-yl)-N-(4-methyl-2-pyrimidinyl)benzenesulfonamides (1-9), was designed and synthesized by the diazo reaction between sulfamerazine and substituted aromatic amines for the first time. Their chemical structures were characterized by

Identifiants

pubmed: 32984993
doi: 10.1002/ardp.202000243
doi:

Substances chimiques

Carbonic Anhydrase Inhibitors 0
Cholinesterase Inhibitors 0
Triazenes 0
Acetylcholinesterase EC 3.1.1.7
Carbonic Anhydrase I EC 4.2.1.-
Carbonic Anhydrase II EC 4.2.1.-
Sulfamerazine UR1SAB295F

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2000243

Subventions

Organisme : Ataturk University Research Fund, Erzurum, Turkey
ID : Project number: TSA-2020-8222

Informations de copyright

© 2020 Deutsche Pharmazeutische Gesellschaft.

Références

K. V. Nguyen, Neuroscience 2018, 5, 74.
K. O. Yerdelen, H. I. Gul, Med. Chem. Res. 2013, 22, 4920.
D. O. Ozgun, H. I. Gul, C. Yamali, H. Sakagami, I. Gulcin, M. Sukuroglu, C. T. Supuran, Bioorg. Chem. 2019, 84, 511.
L. A. Craig, N. S. Hong, R. J. Mcdonald, Neurosci. Biobehav. Rev. 2011, 35, 1397.
C. H. Trepanier, N. W. Milgram, J. Alzheimer's Dis. 2010, 21, 1089.
M. Goedert, M. G. Spillantini, Science 2006, 314, 777.
D. Praticò, Trends Pharmacol. Sci. 2008, 29, 609.
Y. Huang, L. Mucke, Cell 2012, 148, 1204.
W. Danysz, C. G. Parsons, H.-J. Möbius, A. Stöffler, G. Quack, Neurotoxic. Res. 2000, 2, 85.
D. O. Ozgun, C. Yamali, H. I. Gul, P. Taslimi, I. Gulcin, T. Yanik, C. T. Supuran, J. Enzyme Inhib. Med. Chem. 2016, 31, 1498.
M. B. Colovic, D. Z. Krstic, T. D. Lazarevic-Pasti, A. M. Bondzic, V. M. Vasic, Curr. Neuropharmacol. 2013, 11, 315.
M. Racchi, M. Mazzucchelli, E. Porrello, C. Lanni, S. Govoni, Pharmacol. Res. 2004, 50, 441.
B. Mcgleenon, K. Dynan, A. Passmore, Br. J. Clin. Pharmacol. 1999, 48, 471.
C. T. Supuran, J. Enzyme Inhib. Med. Chem. 2016, 31, 345.
C. T. Supuran, A. Scozzafava, Bioorg. Med. Chem. 2007, 15, 4336.
P. S. Thacker, P. Shaikh, A. Angeli, M. Arifuddin, C. T. Supuran, J. Enzyme Inhib. Med. Chem. 2019, 34, 1172.
P. Taslimi, K. Turhan, F. Türkan, H. S. Karaman, Z. Turgut, I. Gulcin, Bioorg. Chem. 2020, 97, 103647.
C. T. Supuran, Future Med. Chem. 2011, 3, 1165.
C. T. Supuran, Bioorg. Med. Chem. Lett. 2010, 20, 3467.
C. T. Supuran, A. Scozzafava, J. Conway, Carbonic Anhydrase: Its Inhibitors and Activators, Vol. 1, CRC Press, Boca Raton, Florida, 2004.
C. T. Supuran, A. Scozzafava, Expert Opin. Ther. Pat. 2000, 10, 575.
L. Vats, V. Sharma, A. Angeli, R. Kumar, C. T. Supuran, P. K. Sharma, Eur. J. Med. Chem. 2018, 150, 678.
A. Mermer, N. Demirbas, A. Colak, E. A. Demir, N. Kulabas, A. Demirbas, ChemistrySelect 2018, 3, 12234.
D. B. Kimball, M. M. Haley, Angew. Chem., Int. Ed. 2002, 41, 3338.
I. Seck, S. F. Ndoye, L. A. Ba, A. Fall, A. Diop, I. Ciss, A. Ba, C. Sall, A. Diop, C. S. Boye, Curr. Trends Med. Chem. 2020, 20, 713.
M. Işık, S. Akocak, N. Lolak, P. Taslimi, C. Türkeş, İ. Gülçin, M. Durgun, Ş. Beydemir, Arch. Pharm. 2020, 353, e2000102.
S. Bilginer, B. Gonder, H. I. Gul, R. Kaya, I. Gulcin, B. Anil, C. T. Supuran, J. Enzyme Inhib. Med. Chem. 2020, 35, 325.
N. Lolak, S. Akocak, S. Bua, M. Koca, C. T. Supuran, Bioorg. Chem. 2018, 77, 542.
P. Diana, A. Stagno, P. Barraja, A. Carbone, B. Parrino, F. Dall'acqua, D. Vedaldi, A. Salvador, P. Brun, I. Castagliuolo, ChemMedChem 2011, 6, 1291.
A. K. Gadad, C. S. Mahajanshetti, S. Nimbalkar, A. Raichurkar, Eur. J. Med. Chem. 2000, 35, 853.
I. R. Ezabadi, C. Camoutsis, P. Zoumpoulakis, A. Geronikaki, M. Soković, J. Glamočilija, A. Ćirić, Bioorg. Med. Chem. 2008, 16, 1150.
C. T. Supuran, Curr. Pharm. Des. 2008, 14, 641.
V. Zubkov, T. Tsapko, I. Gritsenko, A. Zagayko, L. Galuzinskaya, Russ. Chem. Bull. 2012, 61, 1969.
N. Chandna, S. Kumar, P. Kaushik, D. Kaushik, S. K. Roy, G. K. Gupta, S. M. Jachak, J. K. Kapoor, P. K. Sharma, Bioorg. Med. Chem. 2013, 21, 4581.
A. Scozzafava, T. Owa, A. Mastrolorenzo, C. T. Supuran, Curr. Med. Chem. 2003, 10, 925.
L. F. Castaño, V. Cuartas, A. Bernal, A. Insuasty, J. Guzman, O. Vidal, V. Rubio, G. Puerto, P. Lukáč, V. Vimberg, Eur. J. Med. Chem. 2019, 176, 50.
C. Yamali, H. I. Gul, A. Ece, S. Bua, A. Angeli, H. Sakagami, E. Sahin, C. T. Supuran, Bioorg. Chem. 2019, 92, 103222.
H. I. Gul, C. Yamali, M. Bulbuller, P. B. Kirmizibayrak, M. Gul, A. Angeli, S. Bua, C. T. Supuran, Bioorg. Chem. 2018, 78, 290.
H. I. Gul, C. Yamali, H. Sakagami, A. Angeli, J. Leitans, A. Kazaks, K. Tars, D. O. Ozgun, C. T. Supuran, Bioorg. Chem. 2018, 77, 411.
A. Nocentini, C. T. Supuran, Expert Opin. Drug Discov. 2019, 14, 1175.
P. Tundo, A. Loris, M. Selva, Green Chem. 2007, 9, 777.
R. Lillie, J. Histochem. Cytochem. 1970, 18, 187.
A. Daina, O. Michielin, V. Zoete, Sci. Rep. 2017, 7, 42717.
M. H. Badr, Sa. F. Rostom, M. F. Radwan, Chem. Pharm. Bull. 2017, 65, 442.
C. A. Lipinski, F. Lombardo, B. W. Dominy, P. J. Feeney, Adv. Drug Deliv. Rev. 1997, 23, 3.
K. Kucukoglu, H. I. Gul, P. Taslimi, I. Gulcin, C. T. Supuran, Bioorg. Chem. 2019, 86, 316.
C. Yamali, H. I. Gul, A. Ece, P. Taslimi, I. Gulcin, Chem. Biol. Drug Des. 2018, 91, 854.
H. I. Gul, A. Demirtas, G. Ucar, P. Taslimi, I. Gulcin, Lett. Drug Des. Discov. 2017, 14, 573.
C. Yamali, H. I. Gul, C. Kazaz, S. Levent, I. Gulcin, Bioorg. Chem. 2020, 96, 103627.
G. L. Ellman, K. D. Courtney, V. Andres Jr, R. M. Featherstone, Biochem. Pharmacol. 1961, 7, 88.
G. Mamedova, A. Mahmudova, S. Mamedov, Y. Erden, P. Taslimi, B. Tüzün, R. Tas, V. Farzaliyev, A. Sujayev, S. H. Alwasel, Bioorg. Chem. 2019, 93, 103313.
I. Gulcin, R. Kaya, A. C. Goren, H. Akincioglu, M. Topal, Z. Bingol, K. Cetin Çakmak, S. B. Ozturk Sarikaya, L. Durmaz, S. Alwasel, Int. J. Food Prop. 2019, 22, 1511.
P. Taslimi, F. Türkan, A. Cetin, H. Burhan, M. Karaman, I. Bildirici, İ. Gulçin, F. Şen, Bioorg. Chem. 2019, 92, 103213.
S. Bilginer, H. I. Gul, F. S. Erdal, H. Sakagami, S. Levent, I. Gulcin, C. T. Supuran, J. Enzyme Inhib. Med. Chem. 2019, 34, 1722.
S. Bilginer, H. I. Gul, F. S. Erdal, H. Sakagami, I. Gulcin, Arch. Pharm. 2020, 353, e1900384.
C. Yamali, M. Tugrak, H. I. Gul, M. Tanc, C. T. Supuran, J. Enzyme Inhib. Med. Chem. 2016, 31, 1678.
H. I. Gul, M. Tugrak, M. Gul, S. Mazlumoglu, H. Sakagami, I. Gulcin, C. T. Supuran, Bioorg. Chem. 2019, 90, 103057.
M. Tugrak, H. I. Gul, K. Bandow, H. Sakagami, I. Gulcin, Y. Ozkay, C. T. Supuran, Bioorg. Chem. 2019, 90, 103095.
E. Mete, B. Comez, H. Inci Gul, I. Gulcin, C. T. Supuran, J. Enzyme Inhib. Med. Chem. 2016, 31, 1.
A. Yıldırım, U. Atmaca, A. Keskin, M. Topal, M. Celik, İ. Gülçin, C. T. Supuran, Bioorg. Med. Chem. 2015, 23, 2598.
A. Akıncıoğlu, Y. Akbaba, H. Göçer, S. Göksu, İ. Gülçin, C. T. Supuran, Bioorg. Med. Chem. 2013, 21, 1379.
K. Aksu, M. Nar, M. Tanc, D. Vullo, İ. Gülçin, S. Göksu, F. Tümer, C. T. Supuran, Bioorg. Med. Chem. 2013, 21, 2925.
M. Boztas, Y. Cetinkaya, M. Topal, I. Gulcin, A. Menzek, E. Sahin, M. Tanc, C. T. Supuran, J. Med. Chem. 2015, 58, 640.
A. Scozzafava, M. Passaponti, C. T. Supuran, İ. Gülçin, J. Enzyme Inhib. Med. Chem. 2015, 30, 586.
H. Gocer, A. Aslan, İ. Gülçin, C. T. Supuran, J. Enzyme Inhib. Med. Chem. 2016, 31, 503.

Auteurs

Sinan Bilginer (S)

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ataturk University, Erzurum, Turkey.

Halise I Gul (HI)

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ataturk University, Erzurum, Turkey.

Baris Anil (B)

Department of Chemistry, Faculty of Science, Ataturk University, Erzurum, Turkey.

Yeliz Demir (Y)

Nihat Delibalta Göle Vocational High School, Ardahan University, Ardahan, Turkey.

Ilhami Gulcin (I)

Department of Chemistry, Faculty of Science, Ataturk University, Erzurum, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH